Простатилен®

General characteristics. Structure:

Active ingredient: 5 mg of a prostate of extract (in terms of water-soluble peptides).

Excipient: glycine.

Pharmacological properties:

Pharmacodynamics. Possesses organotropic action on a prostate. Promotes reduction of hypostasis, stagnation of a secret, leukocytic infiltration of a prostate. Normalizes secretory function of epithelial cells. Has antiinflammatory effect.

Has anti-modular activity, interferes with development of thrombosis of venules in a prostate.

Indications to use:

Chronic prostatitis. States after operative measures on a prostate.

Route of administration and doses:

Intramusculary on 5-10 mg, 1 time a day, within 5-10 days. Lyophilisate before introduction waters for injections dissolve in 1-2 ml 0,9% of solution of sodium of chloride or 0,25-0,5% of solution of Procainum, or.

If necessary conduct a repeated course in 1-6 months.

The description of actions of the doctor or patient at the admission of reception of one or several doses

At the admission of one or several doses treatment is not stopped, lengthening of a course of treatment on the number of the missed days of reception is recommended.

Features of use:

And at its cancellation drug has no features of action at the first reception.

Use of drug at chronic diseases of features has no.

To women drug is not appointed.

The indication of special precautionary measures at destruction of unused medicines

There are no special precautionary measures at destruction of drug.

Influence on ability to manage vehicles and mechanisms. Drug does not influence ability to manage vehicles, to work with moving mechanisms and to be engaged in other potentially dangerous types of activity demanding the increased concentration of attention and speed of psychomotor reactions.

Side effects:

Allergic reactions (urticaria).

In case of allergic reactions treatment is stopped, appoint antihistamines.

Interaction with other medicines:

It is not revealed.

Contraindications:

Hypersensitivity, age up to 18 years.

Overdose:

It is not described.

Storage conditions:

At a temperature not above 20 °C. To store in the place, unavailable to children. A period of validity - 3 years. Not to use after the period of validity specified on packaging.

Issue conditions:

According to the recipe

Packaging:

Lyophilisate for preparation of solution for intramuscular introduction, 5 mg. Packaging: on 5 mg of a prostatilen (in terms of water-soluble peptides) in ampoules with an overclamping and a ring of a break of 2 ml or 3 ml from colourless glass, or in ampoules with an overclamping with a notch and a point of 2 ml from colourless glass. 5 ampoules in a blister strip packaging from a film polyvinyl chloride and a foil aluminum or without foil. 1 or 2 blister strip packagings (with a foil or without foil) together with the application instruction in a pack from a cardboard, or 5 ampoules together with the application instruction in a pack from a cardboard